BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27234765)

  • 1. Efficacy and Feasibility of Low-Dose Rate Brachytherapy for Prostate Cancer in Renal Transplant Recipients.
    Iizuka J; Hashimoto Y; Hashimoto Y; Kondo T; Takagi T; Nozaki T; Shimizu T; Akimoto T; Ishida H; Karasawa K; Tanabe K
    Transplant Proc; 2016 Apr; 48(3):910-3. PubMed ID: 27234765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Feasibility of Intensity-Modulated Radiation Therapy for Prostate Cancer in Renal Transplant Recipients.
    Iizuka J; Hashimoto Y; Hashimoto Y; Kondo T; Takagi T; Nozaki T; Shimizu T; Akimoto T; Ishida H; Karasawa K; Tanabe K
    Transplant Proc; 2016 Apr; 48(3):914-7. PubMed ID: 27234766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose-rate brachytherapy for prostate cancer in renal transplant recipients.
    Rivero-Belenchón I; Osmán-García I; Congregado-Ruíz CB; Cabrera-Roldán P; Jiménez-Torres MJ; Baeza-Trujillo M; Lendínez-Cano G; Conde-Sánchez JM; Argüelles-Salido E; Ortiz-Gordilo MJ; Medina-López RA
    Brachytherapy; 2018; 17(5):808-815. PubMed ID: 29970298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Dose-Rate and High-Dose-Rate Brachytherapy for Localized Prostate Cancer in ABO-Incompatible Renal Transplant Recipients.
    Tasaki M; Kasahara T; Kaidu M; Kawaguchi G; Hara N; Yamana K; Maruyama R; Takizawa I; Ishizaki F; Saito K; Nakagawa Y; Ikeda M; Umezu H; Nishiyama T; Aoyama H; Tomita Y
    Transplant Proc; 2019 Apr; 51(3):774-778. PubMed ID: 30979463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robot-Assisted Radical Prostatectomy for Localized Prostate Cancer in Asian Renal Transplant Recipients.
    Iizuka J; Hashimoto Y; Kondo T; Takagi T; Inui M; Nozaki T; Omoto K; Shimizu T; Ishida H; Tanabe K
    Transplant Proc; 2016 Apr; 48(3):905-9. PubMed ID: 27234764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodine-125 prostate seed brachytherapy in renal transplant recipients: an analysis of oncological outcomes and toxicity profile.
    Beydoun N; Bucci J; Malouf D
    J Contemp Brachytherapy; 2014 Mar; 6(1):15-20. PubMed ID: 24790617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Brachytherapy for Localized Prostate Cancer in Renal Transplant Recipients.
    Mitsunari K; Kurata H; Ito I; Harada J; Nakamura Y; Matsuo T; Ohba K; Mochizuki Y; Imamura R
    Transplant Proc; 2024 Mar; 56(2):285-289. PubMed ID: 38320870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radical Prostatectomy for Localized Prostate Cancer in Renal Transplant Recipients: 13 Cases Studied at a Single Center.
    Iwamoto K; Iizuka J; Hashimoto Y; Kondo T; Takagi T; Hata K; Unagami K; Okumi M; Ishida H; Tanabe K
    Transplant Proc; 2018 Oct; 50(8):2539-2544. PubMed ID: 30316394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage brachytherapy for recurrent prostate cancer after definitive radiation therapy: A comparison of low-dose-rate and high-dose-rate brachytherapy and the importance of prostate-specific antigen doubling time.
    Kollmeier MA; McBride S; Taggar A; Anderson E; Lin M; Pei X; Weiji S; Voros L; Cohen G; Yamada Y; Zelefsky MJ
    Brachytherapy; 2017; 16(6):1091-1098. PubMed ID: 28838648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose rate brachytherapy as prostate cancer monotherapy reduces toxicity compared to low dose rate palladium seeds.
    Grills IS; Martinez AA; Hollander M; Huang R; Goldman K; Chen PY; Gustafson GS
    J Urol; 2004 Mar; 171(3):1098-104. PubMed ID: 14767279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brachytherapy for clinically localized prostate cancer: optimal patient selection.
    Kollmeier MA; Zelefsky MJ
    Arch Esp Urol; 2011 Oct; 64(8):847-57. PubMed ID: 22052766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic transperitoneal radical prostatectomy in renal transplant recipients: a review of the literature.
    Maestro MA; Gómez AT; Alonso Y Gregorio S; Ledo JC; de la Peña Barthel J; Martínez-Piñeiro L
    BJU Int; 2010 Mar; 105(6):844-8. PubMed ID: 19804426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
    Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I/II trial of single-fraction high-dose-rate brachytherapy-boosted hypofractionated intensity-modulated radiation therapy for localized adenocarcinoma of the prostate.
    Myers MA; Hagan MP; Todor D; Gilbert L; Mukhopadhyay N; Randolf J; Heimiller J; Anscher MS
    Brachytherapy; 2012; 11(4):292-8. PubMed ID: 22464911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Localised Prostate Cancer in Kidney Transplant Patients: A Systematic Review from the EAU Guidelines on Renal Transplantation Panel.
    Hevia V; Boissier R; Rodríguez-Faba Ó; Fraser-Taylor C; Hassan-Zakri R; Lledo E; Regele H; Buddde K; Figueiredo A; Olsburgh J; Breda A
    Eur Urol Focus; 2018 Mar; 4(2):153-162. PubMed ID: 29921544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Feasibility and toxicity of a single fraction high-dose-rate brachytherapy followed by a course of EBRT for localized prostate cancer: a retrospective study. The Polyclinique Courlancy experience].
    Mallet F; Wdowczyk D; Bruna A; Villena P; Herard A; Amory JP; Joffroy P; Pangrazzi T
    Cancer Radiother; 2010 Jan; 14(1):11-8. PubMed ID: 20005765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
    Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
    BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early quality of life outcomes in patients with prostate cancer managed by high-dose-rate brachytherapy as monotherapy.
    Komiya A; Fujiuchi Y; Ito T; Morii A; Yasuda K; Watanabe A; Nozaki T; Iida H; Nomura K; Fuse H
    Int J Urol; 2013 Feb; 20(2):185-92. PubMed ID: 22905941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: a Phase II trial.
    Barkati M; Williams SG; Foroudi F; Tai KH; Chander S; van Dyk S; See A; Duchesne GM
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1889-96. PubMed ID: 21550182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.